Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120118) titled 'Efficacy and Safety of Sequential Multimodal Dose-Fractionated Radiotherapy Following Immunochemotherapy for Recurrent and Metastatic Nasopharyngeal Carcinoma:A Prospective, Single-Arm, Phase II Exploratory Study' on March 10.

Study Type: Interventional study

Study Design: Single arm

Primary Sponsor: Jiangxi Cancer Hospital

Condition: nasopharyngeal carcinoma

Recruitment Status: Not Recruiting

Phase: 2

Date of First Enrollment: 2026-03-10

Target Sample Size: Test group:24;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=311480

Disclaimer: Curated b...